Abstract
The presented work deals with the development and comprehensive validation of a quantitative LC–electrospray ionization (ESI)–tandem mass spectrometry (MS/MS) method using a triple quadrupole instrument in the MRM mode for the metabolic profiling of amino acids, organic acids, vitamins, some biogenic amines, secondary metabolites of β-lactam antibiotics biosynthesis as well as their intermediates, and degradation products in fermentation broths of β-lactam antibiotics production (in total 57 hydrophilic compounds). A great number of chromatographic systems (22 different stationary phase/mobile phase conditions) were screened for their adequate chromatographic selectivity to cope with isobaric compounds and other critical analyte pairs. Finally, a hydrophilic interaction liquid chromatography (HILIC) method employing a zwitterionic ZIC-HILIC column was selected as best compromise. Particular focus was given on the elucidation of absolute and relative matrix effects via comparison of slopes of calibration functions of spiked matrix and standard solutions. These data as well as precision and accuracy data confirm suitability of the HILIC–ESI–MS/MS assay for metabolic profiling studies in fermentation samples. Detailed comprehensive data sets are presented which should illustrate critical issues, problems, and challenges of multitarget quantitative metabolic profiling and should outline possible strategies to circumvent pitfalls and overcome common problems.
Similar content being viewed by others
References
Elander RP (2003) Appl Microbiol Biotechnol 61:385–392
Oldiges M, Luetz S, Pflug S, Schroer K, Stein N, Wiendahl C (2007) Appl Microbiol Biotechnol 76:495–511
Weckwerth W, Fiehn O (2002) Curr Opin Biotechnol 13:156–160
Holmes E, Tang H, Wang Y, Seger C (2006) Planta Med 72:771–785
Dettmer K, Aronov PA, Hammock BD (2007) Mass Spectrom Rev 26:51–78
Lu W, Bennett BD, Rabinowitz JD (2008) J Chromatogr B 871:236–242
Lu X, Zhao X, Bai C, Zhao C, Lu G, Xu G (2008) J Chromatogr B 866:64–76
Issaq HJ, Abbott E, Veenstra TD (2008) J Sep Sci 31:1936–1947
Timischl B, Dettmer K, Oefner PJ (2008) Anal Bioanal Chem 391:895–898
Bedair M, Sumner LW (2008) Trends Anal Chem 27:238–250
Theodoridis G, Gika HG, Wilson ID (2008) Trends Anal Chem 27:251–260
Issaq HJ, Van QN, Waybright TJ, Muschik GM, Veenstra TD (2009) J Sep Sci 32:2183–2199
Dunn WB, Ellis DI (2005) Trends Anal Chem 24:285–294
Idborg H, Zamani L, Edlund P-O, Schuppe-Koistinen I, Jacobsson SP (2005) J Chromatogr B 828:9–13
Kaddurah-Daouk R, Kristal BS, Weinshilboum RM (2008) Annu Rev Pharmacol Toxicol 48:653–683
Gika HG, Macpherson E, Theodoridis GA, Wilson ID (2008) J Chromatogr B 871:299–305
Gika HG, Theodoridis GA, Wilson ID (2008) J Sep Sci 31:1598–1608
Kell DB, Brown M, Davey HM, Dunn WB, Spasic I, Oliver SG (2005) Nat Rev Microbiol 3:557–565
Mapelli V, Olsson L, Nielsen J (2008) Trends Biotechnol 26:490–497
Carrau FM, Medina K, Farina L, Boido E, Henschke PA, Dellacassa E (2008) FEMS Yeast Res 8:1196–1207
Kaderbhai NN, Broadhurst DI, Ellis DI, Goodacre R, Kell DB (2003) Comp Funct Genomics 4:376–391
Lu W, Kimball E, Rabinowitz JD (2006) J Am Soc Mass Spectrom 17:37–50
Morgenthal K, Wienkoop S, Scholz M, Selbig J, Weckwerth W (2005) Metabolomics 1:109–121
Bicalho B, David F, Rumplel K, Kindt E, Sandra P (2008) J Chromatogr A 1211:120–128
Tian J, Sang P, Gao P, Fu R, Yang D, Zhang L, Zhou J, Wu S, Lu X, Li Y, Xu G (2009) J Sep Sci 32:2281–2288
Bajad SU, Lu W, Kimball EH, Yuan J, Peterson C, Rabinowitz JD (2006) J Chromatogr A 1125:76–88
Luo B, Groenke K, Takors R, Wandrey C, Oldiges M (2007) J Chromatogr A 1147:153–164
Soga T, Ohashi Y, Ueno Y, Naraoka H, Tomita M, Nishioka T (2003) J Proteome Res 2:488–494
Timischl B, Dettmer K, Kaspar H, Thieme M, Oefner PJ (2008) Electrophoresis 29:2203–2214
Ramautar R, Somsen GW, de Jong GJ (2009) Electrophoresis 30:276–291
Büscher JM, Czernik D, Ewald JC, Sauer U, Zamboni N (2009) Anal Chem 81:2135–2143
Schiesel S, Laemmerhofer M, Lindner W (2009) Anal Bioanal Chem. doi:10.1007/s00216-009-3340-5
Alpert AJ (1990) J Chromatogr 499:177–196
Guo Y, Gaiki S (2005) J Chromatogr A 1074:71–80
Hemstroem P, Irgum K (2006) J Sep Sci 29:1784–1821
Langrock T, Czihal P, Hoffmann R (2006) Amino Acids 30:291–297
Schlichtherle-Cerny H, Affolter M, Cerny C (2003) Anal Chem 75:2349–2354
Chaimbault P, Petritis K, Elfakir C, Dreux M (1999) J Chromatogr A 855:191–202
Coulier L, Bas R, Jespersen S, Verheij E, Van der Werf MJ, Hankemeier T (2006) Anal Chem 78:6573–6582
Huck JHJ, Struys EA, Verhoeven NM, Jakobs C, van der Knaap MS (2003) Clin Chem 49:1375–1380
Mariella Zoppa LG, Zacchello F, Giordano G (2006) J Chromatogr B 831:267–273
Seifar RM, Zhao Z, van Dam J, van Winden W, van Gulik W, Heijnen JJ (2008) J Chromatogr A 1187:103–110
Laemmerhofer M, Richter M, Wu J, Nogueira R, Bicker W, Lindner W (2008) J Sep Sci 31:2572–2588
Nguyen HP, Schug KA (2008) J Sep Sci 31:1465–1480
Matuszewski BK, Constanzer ML, Chavez-Eng CM (2003) Anal Chem 75:3019–3030
Taylor PJ (2005) Clin Biochem 38:328–334
Beaudry F, Vachon P (2006) Biomed Chromatogr 20:200–205
King R, Bonfiglio R, Fernandez-Metzler C, Miller-Stein C, Olah T (2000) J Am Soc Mass Spectrom 11:942–950
Tang K, Page JS, Smith RD (2004) J Am Soc Mass Spectrom 15:1416–1423
Mei H (2005) Matrix effects: causes and solutions. In: Korfmacher WA (ed) Using mass spectrometry for drug metabolism studies. CRC, Boca Raton, pp 103–150
Bicker W, Laemmerhofer M, Keller T, Schuhmacher R, Krska R, Lindner W (2006) Anal Chem 78:5884–5892
Stokvis E, Rosing H, Beijnen JH (2005) Rapid Commun Mass Spectrom 19:401–407
Wang S, Cyronak M, Yang E (2007) J Pharm Biomed Anal 43:701–707
Mashego MR, Rumbold K, Mey M, Vandamme E, Soetaert W, Heijnen JJ (2007) Biotechnol Lett 29:1–16
Boettcher C, Roepenack-Lahaye EV, Willscher E, Scheel D, Clemens S (2007) Anal Chem 79:1507–1513
Beltran E, Ibanez M, Sancho JV, Hernandez F (2009) Rapid Commun Mass Spectrom 23:1801–1809
Villagrasa M, Guillamon M, Eljarrat E, Barcelo D (2007) J Chromatogr A 1157:108–114
Matuszewski BK (2006) J Chromatogr B 830:293–300
FDA (2001) Guidance for industry. Bioanalytical method validation, Food and Drug Administration, Rockville
Wu L, Mashego MR, Van Dam JC, Proell AM, Vinke JL, Ras C, Van Winden WA, Van Gulik WM, Heijnen JJ (2005) Anal Biochem 336:164–171
Acknowledgements
Financial support by the Austrian Christian Doppler Research Society and the industry partner Sandoz (Kundl, Austria) is gratefully acknowledged.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM 1
(PDF 1454 kb)
Rights and permissions
About this article
Cite this article
Schiesel, S., Lämmerhofer, M. & Lindner, W. Multitarget quantitative metabolic profiling of hydrophilic metabolites in fermentation broths of β-lactam antibiotics production by HILIC–ESI–MS/MS. Anal Bioanal Chem 396, 1655–1679 (2010). https://doi.org/10.1007/s00216-009-3432-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-009-3432-2